Back to Search
MICHAEL GALE, DMD
DMD
Dentist
NPI: 1093936734Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*.
PMID 19656286·J Viral Hepat·2010
8-other
The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses.
PMID 19026648·Gastroenterology·2009
8-other
Pegylated interferon and ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatment.
PMID 19673650·J Infect Dis·2009
8-other
Evasion and disruption of innate immune signalling by hepatitis C and West Nile viruses.
PMID 19341437·Cell Microbiol·2009
6-review
Regulation of interferon production and innate antiviral immunity through translational control of IRF-7.
PMID 18385680·Cell Res·2008
7-preclinical
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.
PMID 18548002·Nature·2008
7-preclinical
Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.
PMID 18562536·J Virol·2008
4-observational
A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.
PMID 18628463·Clin Cancer Res·2008
3-trial
Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1.
PMID 17977974·J Virol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 164 FERRY ST, JACKSON STREET ENTRANCE
NEWARK, NJ 07105 - Phone
- (973) 589-5227
Quick Facts
- NPI
- 1093936734
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile